FDA would create electronic drug-tracking system under legislation

Federal legislators this week unveiled a bill that calls on the U.S. Food and Drug Administration to develop an electronic system for tracking pharmaceuticals "from manufacturing to distribution."

The bill--known as the Drug Quality and Security Act--initially was unveiled in April as a draft bill by Sens. Michael Bennet (D-Colo.), Richard Burr (R-N.C.), Tom Harkin (D-Iowa) and Lamar Alexander (R-Tenn.). It is meant to replace the current "patchwork of state prescription-drug tracing laws" by creating a national uniform framework.

"Plain and simple, this legislation will help ensure that providers and their patients have access to high-quality compounded drugs," Harkin said in a statement. "This legislation will improve the safety of compounded drugs by clarifying the oversight responsibilities of the FDA over large-volume compounders and by holding facilities to high quality standards."

The legislation, according to Alexander, was crafted, in part, as a response to a meningitis outbreak to a 2012 meningitis outbreak that caused 58 deaths and more than 700 sick individuals. The outbreak occurred after a Massachusetts compounding pharmacy produced tainted steroids.

"The FDA commissioner has warned us that an outbreak like this will happen again if we don't clarify oversight, so I have worked hard with my colleagues in the House and Senate to make it clear at every compounding facility who's on the flagpole--who's in charge--of overseeing their compounding practices," Alexander said in a statement.

Lawmakers and the governor in Pennsylvania are backing creation of a database of prescriptions for habit-forming drugs. The state already has a prescription-monitoring database, but it's limited to powerful painkillers including Fentanyl, Oxycodone and Percocet.

Missouri remains the only state that has not at least passed legislation to create a prescription-monitoring program. Yet experts say "doctor shopping" for painkillers remains a daily problem largely because those monitoring programs don't carry tough consequences for inappropriate prescribers.

To learn more:
- here's the announcement

Suggested Articles

The Office for Civil Rights is ramping up its focus on the Right of Access Initiative, which ensures patients timely access to their medical records.

Mount Sinai is launching a diversity and inclusion hub to serve as an incubator for new technology and to help diversify the pipeline in innovation.

CVS Health is joining forces with UPS to test several different applications for drone delivery, including sending products directly to patients.